Literature DB >> 18239361

Fluorine-19 fast recovery fast spin echo imaging for mapping 5-fluorouracil.

Shigehiro Morikawa1, Toshiro Inubushi, Masahito Morita, Koichiro Murakami, Chiaki Masuda, Jun-ichi Maki, Ikuo Tooyama.   

Abstract

We investigated the effects of fast recovery (FR) to increase the sensitivity of fluorine-19 ((19)F) fast spin echo (FSE) in mapping 5-fluorouracil (5-FU) and its metabolites. We added an additional 90 degrees pulse (which flips back longitudinal magnetization at the end of the sequence) to the chemical shift selective (19)F FSE pulse sequence. In 5-FU solution, FR remarkably improved the signal-to-noise (S/N) ratio of (19)F 5-FU images, having higher effects with shorter repetition time and smaller echo train numbers. In animal studies, FR produced a conspicuous increase in (19)F signals in the urinary bladder. FR effects for (19)F signals in the liver were smaller than those in other organs but still substantial. Utilization of FR in (19)F FSE images promises more sensitive observation of (19)F metabolite maps of 5-FU and other (19)F-containing compounds that have relatively long relaxation times.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18239361     DOI: 10.2463/mrms.6.235

Source DB:  PubMed          Journal:  Magn Reson Med Sci        ISSN: 1347-3182            Impact factor:   2.471


  2 in total

1.  Toward 19F magnetic resonance thermometry: spin-lattice and spin-spin-relaxation times and temperature dependence of fluorinated drugs at 9.4 T.

Authors:  Christian Prinz; Paula Ramos Delgado; Thomas Wilhelm Eigentler; Ludger Starke; Thoralf Niendorf; Sonia Waiczies
Journal:  MAGMA       Date:  2018-12-04       Impact factor: 2.310

2.  In vivo detection of teriflunomide-derived fluorine signal during neuroinflammation using fluorine MR spectroscopy.

Authors:  Christian Prinz; Ludger Starke; Jason M Millward; Ariane Fillmer; Paula Ramos Delgado; Helmar Waiczies; Andreas Pohlmann; Michael Rothe; Marc Nazaré; Friedemann Paul; Thoralf Niendorf; Sonia Waiczies
Journal:  Theranostics       Date:  2021-01-01       Impact factor: 11.556

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.